License Agreement Summary Sample Clauses

License Agreement Summary. The following summary contains an overview of the key points of the Agreement. Note that this summary should not be considered a complete, accurate, and binding description of the terms and conditions of the Agreement. The summary is merely provided for your personal convenience, and does not bind you or Altsoft in any way. The terms and conditions described below under the heading Full License Agreement constitute the only legally valid and binding elements of the Agreement. • Licenses are PER CUSTOMER. The XML2PDF API Company Wide license entitles you to: o make [x] copies of the Software on a maximum of [x] machines (hereafter referred to as “Development Systems”). On each Development System, the Software may be integrated in unmodified form into your own software (hereafter referred to as the “Non-Altsoft Code”). Note that the license allows up to [x] people to work simultaneously on the development on up to [x] Development Systems, but only if: ▪ All developers who come into contact with the Software source code are employed exclusively by you. Specifically, no development work may be done on the Development Systems by independent contractors, interns, trainees, volunteers, or employees who are engaged in part-time employment for a different employer than you, if this development work allows them access to the Software source code. ▪ Additionally, all Development Systems must be under your exclusive control, either as a result of your exclusive ownership of the Development Systems, or following an exclusive lease agreement or similar arrangement which precludes any and all third parties from accessing any information on your system without your prior knowledge and consent, or without a legal requirement to comply with the binding orders of any regulatory authority or as required by law or by judicial decree. o run one copy of the Non-Altsoft Code containing the integrated Software on one machine (hereafter referred to as the “Runtime System”). The Runtime System may be used as a server, including as a web server if desired, and the license allows an unlimited amount of users to use the Non-Altsoft Code containing the integrated Software through the Runtime System. • However, you may not sell and/or redistribute the Software in any form, including after integration into any Non-Altsoft Code, as the license is non-transferable. Should you wish to redistribute any Non-Altsoft Code containing the Software, you will need to acquire a redistributable licens...
AutoNDA by SimpleDocs
License Agreement Summary. The License Agreement Term is the length of time between the Starting Date and the Ending Date. Starting Date is XXXXX XX, 20XX and the Ending Date is XXXX XX, 20XX. The Resident’s assigned space shall be used and occupied by Resident for residential purposes only. The Residence Life Staff at Massachusetts College of Art and Design shall assign Resident to the Premises at the beginning of the Term; provided, however, that the College reserves the right to reassign Resident to other accommodations for cause(s) deemed sufficient by the Office of Housing and Residence Life. In the event of reassignment, this Agreement will remain in effect and will apply to the Resident’s occupancy of that other space, the College will provide the Resident with ten (10) days written notice in the event that it elects to reassign the Resident to another bedroom. This Agreement is for a bedroom, and at no time shall be interpreted to refer to a specific unit within the building. The College will determine the specific Bedroom and Unit Number on or before the Starting Date.
License Agreement Summary. Shionogi has granted GARDP a non-exclusive and sub-licensable license for cefiderocol in the territory outlined below (“Territory”) to develop, register, manufacture and commercialize cefiderocol, all in accordance with the terms of the agreement. Territory technology transfer The Territory covers 135 countries, almost 70% of countries worldwide, including countries with some of the highest burden of infections due to resistant pathogens for which cefiderocol is indicated. The license agreement will include the payment of cost recoupment fees to Shionogi on net sales made in certain parts of the Territory: • High-income countries: 9% • Upper middle-income countries: 5% • Lower middle-income countries: 0% • Low-income countries: 0% Technology transfer and intellectual property If a manufacturer requests a technology transfer, Shionogi will provide one technology transfer of its manufacturing process, including relevant know-how, to one manufacturing sub-licensee (or, if the manufacturers of the active pharmaceutical ingredient (API) and finished pharmaceutical product are different, then one technology transfer covering the complete development from API to finished pharmaceutical product, but to two different manufacturers). In addition, Shionogi will provide access to documents and necessary rights of referral to enable product registrations at national regulatory bodies and at the WHO Prequalification Programme (PQ). Additional and subsequent sublicensees will be provided relevant technology transfer, including documentation, by either GARDP (including via a third party), CHAI, or the sublicensee that received the initial technology transfer.
License Agreement Summary. The following summary contains an overview of the key points of the Agreement. Note that this summary should not be considered a complete, accurate, and binding description of the terms and conditions of the Agreement. The summary is merely provided for your personal convenience, and does not bind you or Altsoft in any way. The terms and conditions described below under the heading Full License Agreement constitute the only legally valid and binding elements of the Agreement. • Licenses are PER CUSTOMER. A single redistributable license license entitles you to: o Install the software on as much servers/computers as needed; clients included. o Sell and/or redistribute the Software in any form, including after integration into any Non-Altsoft Code. • The Software is provided on an AS-IS BASIS, without any warranties, express, implied or statutory, with regard to merchantability or fitness for a particular purpose, except where expressly provided otherwise in the Full License Agreement or as required by law. • The Agreement entitles you to no support as support is provided on a per ticket or per hour basis. • The validity and interpretation of the Agreement is EXCLUSIVELY SUBJECT TO BELGIAN LAW, and any disputes resulting from or in connection to the Agreement may be only be presented before the competent courts of Leuven, Belgium.
License Agreement Summary. The following summary contains an overview of the key points of the Agreement. Note that this summary should not be considered a complete, accurate, and binding description of the terms and conditions of the Agreement. The summary is merely provided for your personal convenience, and does not bind you or Altsoft in any way. The terms and conditions described below under the heading Full License Agreement constitute the only legally valid and binding elements of the Agreement. • Licenses are PER CUSTOMER. A single license entitles you to: o make one copy of the Software on one machine (hereafter referred to as the “Development System”). On the Development System, the Software may be integrated in unmodified form into your own software (hereafter referred to as the “Non-Altsoft Code”). Note that the license allows multiple people to work on the development on the Development System, but not simultaneously. Only one person at a time may work on integrating the Software into the Non-Altsoft Code. If you wish for additional developers to work on the development process simultaneously, or if you wish to copy the Software on other machines than the Development System, you will need to acquire additional developer licenses from Altsoft (contact xxxxx@xxx-xxxx.xxx ).

Related to License Agreement Summary

  • License Agreement The Trust shall have the non-exclusive right to use the name "Invesco" to designate any current or future series of shares only so long as Invesco Advisers, Inc. serves as investment manager or adviser to the Trust with respect to such series of shares.

  • Software License Agreement 1) Customers acquiring software licenses under the Contract shall hold, use and operate such software subject to compliance with the Software License Agreement set forth in Appendix D of this Contract. No changes to the Software License Agreement terms and conditions may be made unless previously agreed to between Vendor and DIR. Customers may not add, delete or alter any of the language in Appendix D; provided however, that a Customer and Vendor may agree to additional terms and conditions that do not diminish a term or condition in the Software License Agreement, or in any manner lessen the rights or protections of Customer or the responsibilities or liabilities of Vendor. Order Fulfiller shall make the Software License Agreement terms and conditions available to all Customers at all times.

  • License Agreements (a) Each Borrower and Guarantor shall (i) promptly and faithfully observe and perform all of the material terms, covenants, conditions and provisions of the material License Agreements to which it is a party to be observed and performed by it, at the times set forth therein, if any, (ii) not do, permit, suffer or refrain from doing anything that could reasonably be expected to result in a default under or breach of any of the terms of any material License Agreement, (iii) not cancel, surrender, modify, amend, waive or release any material License Agreement in any material respect or any term, provision or right of the licensee thereunder in any material respect, or consent to or permit to occur any of the foregoing; except, that, subject to Section 9.19(b) below, such Borrower or Guarantor may cancel, surrender or release any material License Agreement in the ordinary course of the business of such Borrower or Guarantor; provided, that, such Borrower or Guarantor (as the case may be) shall give Agent not less than thirty (30) days prior written notice of its intention to so cancel, surrender and release any such material License Agreement, (iv) give Agent prompt written notice of any material License Agreement entered into by such Borrower or Guarantor after the date hereof, together with a true, correct and complete copy thereof and such other information with respect thereto as Agent may request, (v) give Agent prompt written notice of any material breach of any obligation, or any default, by any party under any material License Agreement, and deliver to Agent (promptly upon the receipt thereof by such Borrower or Guarantor in the case of a notice to such Borrower or Guarantor and concurrently with the sending thereof in the case of a notice from such Borrower or Guarantor) a copy of each notice of default and every other notice and other communication received or delivered by such Borrower or Guarantor in connection with any material License Agreement which relates to the right of such Borrower or Guarantor to continue to use the property subject to such License Agreement, and (vi) furnish to Agent, promptly upon the request of Agent, such information and evidence as Agent may reasonably require from time to time concerning the observance, performance and compliance by such Borrower or Guarantor or the other party or parties thereto with the material terms, covenants or provisions of any material License Agreement.

  • End User License Agreement This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. xxxx://xxxxxxxxxxxxxxx.xxx/licenses/by-nc-nd/3.0/ You are free to: Share: to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work).

  • Sublicense Agreements Sublicenses shall be granted only pursuant to written agreements, which shall be subject and subordinate to the terms and conditions of this Agreement. Such Sublicense agreements shall contain, among other things, provisions to the following effect:

  • Collaboration Agreement The Collaboration Agreement shall not have been terminated in accordance with its terms and shall be in full force and effect.

  • Termination of License Agreement This Agreement will terminate automatically in the event that the License Agreement is terminated, provided that prior to such termination of this Agreement becoming effective, the Parties shall cooperate to wind down the activities being conducted hereunder as set forth in Section 15.5(b).

  • Supply Agreement Seller and Buyer, or their Affiliates, shall have executed the Supply Agreement.

  • Client Agreement 2.1. The Company may unilaterally change any terms of this Client Agreement for any of the following reasons:

  • Agreement Scope The scope of this Agreement is as prescribed in section 46 of the Act, setting out: • the health services to be provided to the State by the HSP, • the TTR in support of the health services to be provided, • the funding to be provided to the HSP for the provision of the health services, including the way in which the funding is to be provided, • the performance measures and operational targets for the provision of the health services by the HSP, • how the evaluation and review of results in relation to the performance measures and operational targets is to be carried out, • the performance data and other data to be provided by the HSP to the Department CEO, including how, and how often, the data is to be provided, and • any other matter the Department CEO considers relevant to the provision of the health services by the HSP. Where appropriate, reference will be made in this Agreement to Policy Frameworks issued by the Department CEO pursuant to Part 3, Division 2 of the Act.

Time is Money Join Law Insider Premium to draft better contracts faster.